Older adults' views on geriatric tests for cancer treatment planning
Part of Cancer clinical trials.
This study asks adults aged 65 and older about their views on geriatric and functional assessments to help plan cancer treatment. It tests whether these assessments are acceptable and useful to patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You have started a new cancer treatment within the last 30 days or are about to start one.
- You can understand and answer questions in English.
- You are able to give your own consent to participate.
- You do not already use an activity tracker (like a Fitbit) every day.
- You are not in another study that focuses on physical activity as a major part or that shares activity information with you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a short questionnaire (the sG8 scale) to help doctors better understand the overall health of older adults with cancer. By answering a few questions, you may help doctors plan treatments that are safer and more effective for people your age.
This trial tests whether remote health assessments and support can improve care for adults 65+ who are starting a new cancer treatment. You'd participate from home via telehealth visits.
This study is developing a simple screening tool to help doctors better understand the overall health and needs of older cancer patients (65+). It aims to make sure elderly patients get the right support during cancer treatment.
This study examines why some older adults develop changes in their blood cells that may affect their health. Researchers will look for links between these blood changes, aging, and common health problems in older people.
This study looks at how a geriatric assessment can help older adults with early-stage lung cancer who are getting a precise type of radiation therapy called SBRT. The goal is to understand their needs and improve care.
This study looks at whether geriatric (age-related health) evaluations help doctors choose better treatment for newly diagnosed AML (a type of leukemia). It may help translate older adults’ needs into a clearer, safer treatment plan.
Hear when a new Geriatric Assessment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.